Epigenetic changes may contribute to the pathogenesis of cholesteatoma through dysregulation of several biological pathways. Further studies identifying specific targets such as miRNA-21 and those investigating DNA methylation and histone modifications have the potential to develop biomarkers and targeted pharmaceutical agents for the treatment of cholesteatoma.
Building similarity graph...
Analyzing shared references across papers
Loading...
Brar et al. (Wed,) studied this question.
www.synapsesocial.com/papers/69a75c6cc6e9836116a254da — DOI: https://doi.org/10.1002/ohn.70135
Tripti Brar
Ashley Catanzarite
Priya Arya
Otolaryngology
Emory University
Albert Einstein College of Medicine
Augusta University
Building similarity graph...
Analyzing shared references across papers
Loading...